IQVIA executive testifies before Congress on early clinical trials

Go back to IQVIA executive testifies before Congress on early clinical trials
(NYSE: IQV) Delayed: 207.32 +8.80 (4.43%)
Previous Close $198.52    52 Week High
Open $216.66    52 Week Low
Day High $217.05    P/E N/A 
Day Low $204.15    EPS
Volume 1,351,962